Given the recognised role of SREBP1 as a powerful activator of SCD1 gene transcription (Horton et al, 2003; Ettinger et al, 2004), we investigated the effects of NFs and CAFs on its expression and ability to bind to the SREs on the SCD1 promoter in tumor cells. The gene discussed is SCD; the disease is neoplasm.